A Carboxy-terminal Region of the Hepatitis B Virus X Protein Promotes DNA Interaction of CREB and Mimics the Native Protein for Transactivation Function

被引:0
作者
Honey Reddi
Ravinder Kumar
Swatantra Kumar Jain
Vijay Kumar
机构
[1] Virology Group,
[2] International Centre for Genetic Engineering and Biotechnology,undefined
[3] ENH Research Institute,undefined
来源
Virus Genes | 2003年 / 26卷
关键词
cell transfection; CREB; DNA binding; HBx; Hepatitis B virus; tandem repeats; transactivation;
D O I
暂无
中图分类号
学科分类号
摘要
Earlier we had shown that the conserved region E (residues 120–140) of HBV X protein (HBx) is crucial for transactivation. To investigate this region further, its oligomerisation was considered necessary to augment intracellular biochemical stability. Two to ten unit long tandem repeats of the E region (X16-n) were generated and their expression vectors constructed. Transient transfection of the E expression vectors along with different CAT constructs showed increase in the reporter activity. Interestingly a direct correlation was observed between the number of E repeat units in an expression vector and the level of transactivation. The transactivation levels with decameric X16 on different reporter constructs were comparable to those of the wild type HBx. Co-expression of X16 in a stable CHO-K1 cell line expressing the native HBx, showed co-operativity for transactivation. Further, X16 facilitated the binding of cAMP response element binding protein (CREB) to its responsive element just like the native HBx. The present study suggests that the C-terminal 'E' region of HBx represents its transactivation domain that acts by promoting the interaction of transcription factors to their cognate response elements.
引用
收藏
页码:227 / 238
页数:11
相关论文
共 197 条
[1]  
Brechot C.(2000)undefined Semin Cancer Biol 10 211-231
[2]  
Gozuacik D.(2001)undefined J Gastroenterol 36 651-660
[3]  
Murakami Y.(1996)undefined Adv Virus Res 47 253-302
[4]  
Paterlini-Brechot P.(1997)undefined Mol Cell Biol 17 6427-6436
[5]  
Murakami S.(2001)undefined FEBS Lett 504 59-64
[6]  
Caselmann W.H.(2001)undefined J Virol 75 10348-10358
[7]  
Klein N.P.(2001)undefined J Biol Chem 276 34671-34678
[8]  
Schneider R.J.(2000)undefined Oncogene 19 3384-3394
[9]  
Nijhara R.(2001)undefined J Virol 75 4247-4257
[10]  
Jana S.S.(2001)undefined J Biol Chem 276 8328-8340